Home

Thomas Bures

CIK 1787029 · Chief Accounting Officer · last filed 2026-02-18

Thomas Bures is a Chief Accounting Officer who has filed 7 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider had shares withheld for taxes covering $10.0K of BRKRP on Feb 18, 2026. Across all open-market trades the lifetime net is +$23.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.70M

Companies

3

Total Filings

7

Lifetime Open-Market Net

$23.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BRKRP Chief Accounting Officer 3,198 $463.98 $1.48M $0 1 2026-02-18
BRKR Chief Accounting Officer 3,472 $62.91 $218.4K $23.7K 2 2025-03-11
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Chief Financial Officer — $13.60 — $0 4 2023-02-28

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-18 BRKRP Tax (F) −274 -$10.0K EDGAR
2025-03-11 BRKR Buy (P) +500 $23.7K EDGAR
2025-02-19 BRKR Grant (A) +2,972 $0 EDGAR
2023-02-28 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
2022-02-24 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
2021-03-08 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
2020-03-02 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.